financetom
Business
financetom
/
Business
/
What's Going On With Blackstone & KKR Shares Thursday?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
What's Going On With Blackstone & KKR Shares Thursday?
May 9, 2024 11:23 AM

Blackstone Inc. ( BX ) and KKR & Co. Inc. ( KKR )  shares are trading higher on Thursday. 

Sony Music Entertainment is reportedly gearing up to compete with private equity firms  Blackstone and KKR to acquire Infocom Corp., a Japanese e-comics provider, in a deal valued at approximately ¥200 billion ($1.3 billion).

A second round of bidding for Teijin Ltd.'s full stake in Infocom is scheduled for May, Bloomberg reported, citing undisclosed sources familiar with the matter.

Sony Group Corp.’s music division is in talks with Japanese fund Integral Corp. The parties are contemplating a full acquisition of Infocom’s shares to privatize the Mecha Comics manga app operator, the report read.

Industrial textiles maker Teijin holds 55.1% of Infocom, according to data compiled by Bloomberg.

The e-comics market is booming within the smartphone ecosystem, with digital manga sales surpassing paper sales at ¥483 billion annually. Mecha Comics competes with rivals like Line Corp., Kakao Corp., and Nippon Telegraph & Telephone Corp.’s manga apps, the report added.

Sony Music Entertainment, beyond its music operations, owns Aniplex, creator of Demon Slayer. It also holds a stake in anime distributor Crunchyroll, a venture with Sony Pictures Entertainment. Meanwhile, Blackstone backs Candle Media, led by ex-Disney execs, and KKR invests in Skydance Media helmed by David Ellison, Bloomberg added.

Price Action: KKR shares are trading higher by 1.86% to $101.52 at last check Thursday, while BX shares are trading higher by 1.78% to $121.93.

Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Niu's Massive China Growth Offsets Global Slump
Niu's Massive China Growth Offsets Global Slump
Nov 17, 2025
Chinese electric scooter company Niu Technologies ( NIU ) stock rose Monday after it reported its third-quarter results. Niu reported a quarterly revenue growth of 65.4% year-over-year (Y/Y) to $237.94 million (1.69 billion Chinese yuan), driven by a 49.1% increase in sales volume complemented by an 11.0% increase in revenues per e-scooter. Adjusted EPADS came in at 14 cents, reversing a loss...
NIQ Global Intelligence Says Essity Chooses it as Primary North America Insights Partner
NIQ Global Intelligence Says Essity Chooses it as Primary North America Insights Partner
Nov 17, 2025
08:59 AM EST, 11/17/2025 (MT Newswires) -- NIQ Global Intelligence ( NIQ ) said Monday that Essity has chosen it as the Sweden-based global hygiene and health company's primary provider of point-of-sale and consumer intelligence data for the US market. Financial details of the partnership weren't disclosed. The companies said the partnership brings Essity's US operations into the same data...
MSCI Chief Operating Officer Baer Pettit to Step Down
MSCI Chief Operating Officer Baer Pettit to Step Down
Nov 17, 2025
08:59 AM EST, 11/17/2025 (MT Newswires) -- MSCI ( MSCI ) said Monday that CD Baer Petti will retire next year as president and chief operating officer, and a member of the board of directors. Petti will continue to serve as president and a director until March 1, and will remain as an advisor to the company for a period...
Merus to License Halozyme Therapeutics' Enhanze Drug Delivery System Under Collaboration
Merus to License Halozyme Therapeutics' Enhanze Drug Delivery System Under Collaboration
Nov 17, 2025
08:58 AM EST, 11/17/2025 (MT Newswires) -- Merus (MRUS) and Halozyme Therapeutics ( HALO ) agreed to a global non-exclusive collaboration and license agreement, the two companies said on Monday. Under the collaboration, Merus has licensed Halozyme's Enhanze drug delivery technology for the development and potential commercialization of subcutaneous administration of petosemtamab, the companies said. Merus will also make an...
Copyright 2023-2026 - www.financetom.com All Rights Reserved